There is considerable interest in signal transduction mechanisms underlying neuroplasticity and the mechanisms for regulating the expression of specific regulatory proteins important for these processes in neurons. The purpose of the proposed studies is to test the following hypotheses: 1) expression of the type I Ca2+/calmodulin sensitive adenylyl cyclase may be controlled, at least in part, by a neurospecific promoter and/or enhancer that limits its expression to subclasses of neurons in the central nervous system and 2) type I calmodulin-sensitive adenylyl cyclase plays an important role for basic signalling mechanisms in the molecular basis of learning and memory. To test these hypotheses Dr. Villacres plans to accomplish the following objectives: 1) Isolate and characterize the 5' upstream DNA sequence for the type I adenylyl cyclase using mouse genomic clones for the type I adenylyl cyclase in order to define its promoter and enhancer elements, 2) synthesize constructs comprised of type I adenylyl cyclase DNA fragments fused to a reporter gene in order to characterize the promoter, 3) generate transgenic mice expressing beta-galactosidase under the control of the type I adenylyl cyclase promoter, and 4) disrupt the type I adenylate cyclase gene in ES cells using the positive-negative selection method. A targeting vector from the genomic clone will be constructed that can be used to disrupt the gene for the type I adenylate cyclase in ES cells. If successful, these cells will be used to develop mice deficient in this enzyme. The availability of specific promoters for subclasses of neurons involved in learning and memory may be a powerful tool for studying these functions in neurons. Furthermore, the disruption of the type I adenylyl cyclase gene in transgenic mice by homologous recombination may provide a better understanding of the role of this enzyme in specific areas of the brain.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Clinical Investigator Award (CIA) (K08)
Project #
5K08NS001653-05
Application #
2519866
Study Section
NST-2 Subcommittee (NST)
Program Officer
Michel, Mary E
Project Start
1993-09-16
Project End
1999-08-31
Budget Start
1997-09-01
Budget End
1999-08-31
Support Year
5
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Washington
Department
Pharmacology
Type
Schools of Medicine
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Edelhoff, S; Villacres, E C; Storm, D R et al. (1995) Mapping of adenylyl cyclase genes type I, II, III, IV, V, and VI in mouse. Mamm Genome 6:111-3
Wu, Z L; Thomas, S A; Villacres, E C et al. (1995) Altered behavior and long-term potentiation in type I adenylyl cyclase mutant mice. Proc Natl Acad Sci U S A 92:220-4
Villacres, E C; Wu, Z; Hua, W et al. (1995) Developmentally expressed Ca(2+)-sensitive adenylyl cyclase activity is disrupted in the brains of type I adenylyl cyclase mutant mice. J Biol Chem 270:14352-7